Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents
LEUKEMIA（2019）
关键词
Acute myeloid leukaemia,Cancer immunotherapy,Cancer therapeutic resistance,Immunoediting,Myelodysplastic syndrome,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要